| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.065 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.054 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.013 | 0.8 |